Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.

BACKGROUND Expression of scatter factor (SF), also known as hepatocyte growth factor (HGF), and its receptor, c-met, is often associated with malignant progression of human tumors, including gliomas. Overexpression of SF/HGF in experimental gliomas enhances tumorigenicity and tumor-associated angiogenesis (i.e., growth of new blood vessels). However, the role of endogenous SF/HGF or c-met expression in the malignant progression of gliomas has not been examined directly. In this study, we tested the hypothesis that human glioblastomas can be SF/HGF-c-met dependent and that a reduction in endogenous SF/HGF or c-met expression can lead to inhibition of tumor growth and tumorigenicity. METHODS Expression of the SF/HGF and c-met genes was inhibited by transfecting glioblastoma cells with chimeric transgenes consisting of U1 small nuclear RNA, a hammerhead ribozyme, and antisense sequences. The effects of reduced SF/HGF and c-met expression on 1) SF/HGF-dependent induction of immediate early genes (c-fos and c-jun), indicative of signal transduction; 2) anchorage-independent colony formation (clonogenicity), an in vitro correlate of solid tumor malignancy; and 3) intracranial tumor formation in immunodeficient mice were quantified. Statistical tests were two-sided. RESULTS Introduction of the transgenes into glioblastoma cells reduced expression of the SF/HGF and c-met genes to as little as 2% of control cell levels. Reduction in c-met expression specifically inhibited SF/HGF-dependent signal transduction (P<.01). Inhibition of SF/HGF or c-met expression in glioblastoma cells possessing an SF/HGF-c-met autocrine loop reduced tumor cell clonogenicity (P =.005 for SF/HGF and P=.009 for c-met) and substantially inhibited tumorigenicity (P<.0001) and tumor growth in vivo (P<.0001). CONCLUSIONS To our knowledge, this is the first successful inhibition of SF/HGF and c-met expression in a tumor model directly demonstrating a role for endogenous SF/HGF and c-met in human glioblastoma. Our results suggest that targeting the SF/HGF-c-met signaling pathway may be an important approach in controlling tumor progression.

[1]  Kunio Matsumoto,et al.  Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor , 1998, Oncogene.

[2]  H. Kataoka,et al.  Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. , 1998, Biochemical and biophysical research communications.

[3]  E. Rosen,et al.  Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents , 1998, Oncogene.

[4]  M. Kojima,et al.  Immunohistochemical examination of c-Met protein expression in astrocytic tumors , 1998, Acta Neuropathologica.

[5]  J. Hamada,et al.  Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines. , 1998, International journal of oncology.

[6]  S. Nakano,et al.  Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. , 1998, Cancer letters.

[7]  Marlys Witte,et al.  Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells , 1998, International journal of cancer.

[8]  K. Nabeshima,et al.  Expression of c‐Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study , 1997, Histopathology.

[9]  L. Schmidt,et al.  Activating mutations for the met tyrosine kinase receptor in human cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Merlino,et al.  Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[11]  E. Rosen,et al.  Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. , 1997, Biochemical and biophysical research communications.

[12]  H. Dietz,et al.  Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence. , 1997, Human molecular genetics.

[13]  E. Rosen,et al.  Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[14]  R. Sharp,et al.  Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. V. Vande Woude,et al.  Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. , 1996, Oncogene.

[16]  M. Weinand,et al.  Scatter factor expression and regulation in human glial tumors , 1996, International journal of cancer.

[17]  K. Matsumoto,et al.  Emerging multipotent aspects of hepatocyte growth factor. , 1996, Journal of biochemistry.

[18]  Carmen Birchmeier,et al.  Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud , 1995, Nature.

[19]  G. Michalopoulos,et al.  Mini-review the Many Faces of Hepatocyte Growth Factor: from Hepatopoiesis to Hematopoiesis Structural Properties of Hgf the Hgf Receptor , 1995 .

[20]  Tetsuo Noda,et al.  Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor , 1995, Nature.

[21]  M. Sharpe,et al.  Scatter factor/hepatocyte growth factor is essential for liver development , 1995, Nature.

[22]  E. Rosen,et al.  Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction , 1994, The Journal of cell biology.

[23]  A. Bardelli,et al.  Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene. , 1994, Cellular and molecular biology.

[24]  G. Carmichael,et al.  Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Galimi,et al.  Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. , 1994, The Journal of biological chemistry.

[26]  G. V. Vande Woude,et al.  Met expression and sarcoma tumorigenicity. , 1993, Cancer research.

[27]  P. Steeg,et al.  Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. , 1993, Oncogene.

[28]  W. Birchmeier,et al.  Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met. , 1993, American journal of respiratory cell and molecular biology.

[29]  H. Kleinman,et al.  Scatter factor induces blood vessel formation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Birchmeier,et al.  Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. , 1992, The EMBO journal.

[31]  E Medico,et al.  Expression of the Met/HGF receptor in normal and neoplastic human tissues. , 1991, Oncogene.

[32]  N. Fausto.  Hepatocyte growth factor receptor and the c-met oncogene Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802?804 , 1991 .

[33]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[34]  K. Gatter,et al.  Monoclonal antibody Ki‐67: its use in histopathology , 1990, Histopathology.

[35]  E. Darżynkiewicz,et al.  The trimethylguanosine cap structure of U1 snRNA is a component of a bipartite nuclear targeting signal , 1990, Cell.

[36]  K. Tashiro,et al.  Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.

[37]  M. Zuker.  On finding all suboptimal foldings of an RNA molecule. , 1989, Science.

[38]  M. Braun,et al.  Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Guthrie,et al.  Spliceosomal snRNAs. , 1988, Annual review of genetics.

[41]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.